CJC-1295

CJC-1295

CAT N°: 32704
Price:

From 48.00 40.80

CJC-1295 is a synthetic peptide derivative of growth hormone-releasing hormone (GHRH).{58178} Unlike CJC-1295-DAC, CJC-1295 does not contain a drug affinity complex (DAC) moiety and has a shorter half-life than the DAC-conjugated version in the blood.{58179} CJC-1295 increases the secretion of growth hormone in primary rat anterior pituitary cells when used from picomolar to micromolar concentrations and into rat blood when administered subcutaneously at a dose of 1 µmol/kg.{58178}

Territorial Availability: Available through Bertin Technologies only in France

  • Synonyms
    • L-tyrosyl-D-alanyl-L-?-aspartyl-L-alanyl-L-isoleucyl-L-phenylalanyl-L-threonyl-L-glutaminyl-L-seryl-L-tyrosyl-L-arginyl-L-lysyl-L-valyl-L-leucyl-L-alanyl-L-glutaminyl-L-leucyl-L-seryl-L-alanyl-L-arginyl-L-lysyl-L-leucyl-L-leucyl-L-glutaminyl-L-?-aspartyl-L-isoleucyl-L-leucyl-L-seryl-L-argininamide
  • Correlated keywords
    • without DAC no DAC ModGRF(1-29) Mod GRF (1-29) CJC1295 CJC1295DAC halflife
  • Product Overview:
    CJC-1295 is a synthetic peptide derivative of growth hormone-releasing hormone (GHRH).{58178} Unlike CJC-1295-DAC, CJC-1295 does not contain a drug affinity complex (DAC) moiety and has a shorter half-life than the DAC-conjugated version in the blood.{58179} CJC-1295 increases the secretion of growth hormone in primary rat anterior pituitary cells when used from picomolar to micromolar concentrations and into rat blood when administered subcutaneously at a dose of 1 µmol/kg.{58178}

We also advise you